Zevia PBC Reports Significantly Reduced Net Loss and Improved Gross Margin for 2025
Summary
Zevia PBC reported a significant reduction in its net loss and improved gross margin for 2025, driven by a productivity initiative, while maintaining liquidity and an unused ATM program.
Key Events
-
Net Loss Significantly Reduced
The company's net loss decreased to $11.2 million in 2025 from $23.8 million in 2024, representing a substantial improvement in profitability.
-
Adjusted EBITDA Shows Strong Improvement
Adjusted EBITDA improved from a loss of $15.2 million in 2024 to a loss of $4.7 million in 2025, reflecting enhanced operational efficiency.
-
Gross Margin Expansion
Gross margin increased to 48.0% in 2025 from 46.4% in 2024, indicating better cost management and pricing.
-
Productivity Initiative Completed
The multi-year Productivity Initiative, which included workforce reduction and cost streamlining, completed its restructuring charges in 2025 and is expected to deliver $20.0 million in annualized benefits through 2026.
Analysis
Zevia PBC reported a substantial improvement in its financial performance for the fiscal year ended December 31, 2025. The company significantly reduced its net loss to $11.2 million from $23.8 million in 2024, and its Adjusted EBITDA improved from a loss of $15.2 million to a loss of $4.7 million. Gross margin also expanded to 48.0% from 46.4%. These operational improvements are largely attributed to a multi-year Productivity Initiative, which completed its restructuring charges in 2025 and is expected to generate $20.0 million in annualized benefits through 2026. The company maintains $25.4 million in cash and has an authorized, but currently unused, $20 million at-the-market (ATM) offering program, providing a potential source of future capital. While the company previously regained compliance with NYSE listing standards, the stock is currently trading near its 52-week low, highlighting ongoing market concerns despite the improved financials. The company also disclosed a potential $58.9 million liability under a Tax Receivable Agreement, though it currently has a full valuation allowance against deferred tax assets, indicating no immediate expectation of these payments.
At the time of this filing, ZVIA was trading at $1.46 on NYSE in the Manufacturing sector, with a market capitalization of approximately $116.3M. The 52-week trading range was $1.49 to $3.66. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.